Randomized controlled trial of traditional Chinese medicine on dilated cardiomyopathy

Not Applicable

• Conditions: Dilated cardiomyopathy

• Registration Number: ITMCTR2100005315
• Lead Sponsor: Guang'anmen Hospital, China Academy of Chinese Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Left ventricular end-diastolic diameter (LVEDd) > 5.0 cm (female), LVEDd > 5.5 cm (male); LVEF < 45%, short axis shortening (LVFS) < 25%; 2. NYHA functional classification II-III; 3. Aged 18-75 years old, male or female, the patient signed the informed consent; 4. Nearly 2 did not take other symptomatic traditional Chinese medicine preparations.

Exclusion Criteria

? Exclusion of viral myocarditis, rheumatic cardiomyopathy, ischemic heart disease, diabetic heart disease, valvular heart disease and other structural heart disease with clear etiology;
? Patients with severe liver and kidney function damage, cancer and mental illness;
? Pregnant and lactating women;
? Patients with severe heart, liver, kidney, blood and nervous system diseases;
? Patients with other causes of uncooperation and poor compliance.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
End-diastolic diameter;Left ventricular ejection fraction;

Secondary Outcome Measures

Name	Time	Method
Safety indicators;NT-proBNP;Left ventricular fractional shortening;6-Minute Walking Distance;TCM score;